Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion type Assertion NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_head.
- NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion description "[XPD Lys751Gln polymorphism may be an important marker in the prediction of clinical outcome to chemo-radiotherapy in resected gastric cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_provenance.
- NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion evidence source_evidence_literature NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_provenance.
- NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion SIO_000772 17009404 NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_provenance.
- NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion wasDerivedFrom befree-20140225 NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_provenance.
- NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_assertion wasGeneratedBy ECO_0000203 NP406528.RAVMfS9uvFf0n5KOc3aqv_eynFygnL2AxGPq74gumfKsI130_provenance.